StonvexLoading…
StonvexStonvexStonvexCore line items from KR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-11-08 | Q3 2025 2025-08-16 | Q2 2025 2025-05-24 |
|---|---|---|---|---|
Revenue | $147.64B | $112.92B | $79.06B | $45.12B |
Operating Income | $1.89B | $644.00M | $2.19B | $1.32B |
Net Income | $1.02B | $155.00M | $1.48B | $866.00M |
EPS (Diluted) | $1.54 | $0.23 | $2.20 | $1.29 |
Total Assets | $49.95B | $51.44B | $53.59B | $53.25B |
Total Liabilities | $44.02B | $44.40B | $44.31B | $44.34B |
Cash & Equivalents | $3.33B | $3.96B | $4.88B | $4.74B |
Free Cash Flow OCF − CapEx | $3.46B | $1.75B | $1.72B | $1.10B |
Shares Outstanding | 655.00M | 662.00M | 664.00M | 664.00M |